Entry Detail



General Information

Database ID:exR0354463
RNA Name:hsa-miR-362-3p
RNA Type:miRNA
Chromosome:chrX
Starnd:+
Coordinate:
Start Site(bp):50009005End Site(bp):50009026
External Links:hsa-miR-362-3p



Disease Information

Disease Name:Glioblastoma Multiforme
Disease Category:Cancers
MeSH ID:D005909
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell



Expression Detail

GEO ID:GSE93850
Description:Serum miRNAs in Patients with Glioblastoma Multiforme
Experimental Design:Cancer vs Control
Case Disease Type:Glioblastoma Multiforme
Case Disease SubType:NA
Case Sample:Glioblastoma Multiforme
Control Sample:Healthy
Number of Case:22
Number of Control:8
Number of Samples:30





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
PTPRJ
chr11
47980558
48170841
+
KIAA0232
chr4
6781375
6884170
+
USF2
chr19
35268962
35279821
+
BLCAP
chr20
37492472
37527931
-
AC009133.6
chr16
29812261
29820092
+
WDR82
chr3
52254434
52288020
-
PIP4K2B
chr17
38765689
38800126
-
ARF3
chr12
48935723
48957487
-
TRPS1
chr8
115408496
115809673
-
UBTF
chr17
44205033
44221626
-
FAM126B
chr2
200973718
201071671
-
ZBTB2
chr6
151364115
151391559
-
TNFRSF21
chr6
47231532
47309905
-
RUNX1
chr21
34787801
36004667
-
MTPN
chr7
135926760
135977359
-
SERTAD3
chr19
40440844
40444335
-
DCBLD2
chr3
98795941
98901695
-
ATP8B1
chr18
57646426
57803315
-
SLF2
chr10
100912963
100965134
+
SDCBP
chr8
58552924
58582859
+
TNFRSF1B
chr1
12166991
12209228
+
COQ8A
chr1
226897536
226987545
+
DNAJB9
chr7
108569867
108574850
+
VAMP2
chr17
8159149
8163546
-
SIK1B
chr21
6111131
6123778
+
SMAP2
chr1
40344850
40423326
+
FAM219A
chr9
34398184
34458570
-
CA12
chr15
63321378
63381846
-
CALM1
chr14
90396502
90408268
+
AKAP11
chr13
42272152
42323261
+
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0001588
chr6
26204839
26205043
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC016876.2
chr17
7581964
7584086
-
KCNQ1OT1
chr11
2608328
2699994
-
MIR663AHG
chr20
26167817
26251546
-
NEAT1
chr11
65422774
65445540
+
SCARNA9
chr11
93721513
93721865
+
SNHG25
chr17
64145970
64146476
+
STAG3L5P-PVRIG2P-PILRB
chr7
100336104
100367831
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE93850
Sample Source:Blood
Source Fraction:Serum
Platform:GPL22948
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:1032
Sample treatment protocol:NA
RNA Extract protocol:Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada)
RNA library preparation protocol:0.3ug of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 ul at 16°C overnight.



Reference

PMID:28931080
Title:Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma
Author:Wang ZQ, Zhang MY, Deng ML, Weng NQ, Wang HY,Wu SX
Journal:PLoS One. 2017 Sep 20;12(9):e0184969.
Description:we investigated whether 3 of the 19 miRNAs in serum could be used as prognostic biomarkers for patients with GBM.